Daniel Ghinn· @creationdaniel · X·· 2 天前评分70
正文 · 原文
During the NATALEE readout, it's the top trending trial in the live HCP conversation at #ESMO26.
For the first time, you can track how HCPs are reacting to trial data as it happens.
Stop by stand 1060a to try it for yourself.
39 浏览 · 1 赞 · 0 转发 · 0 回复
会议摘要
LBA25按 Proffered paper 1: Breast cancer, early and advanced stage 对上
Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes
https://esmocongress.esmo.org来源：Daniel Ghinn · x.com